泽璟制药：关于自愿披露注射用ZGGS34临床试验申请获得FDA批准的公告

Group 1 - The core point of the article is that Zai Lab has received FDA approval for its investigational product ZGGS34 for the treatment of advanced solid tumors [2] Group 2 - The announcement was made on the evening of August 19 [2] - The approval is significant as it allows the company to proceed with clinical trials in the United States [2]